New York, NY (PRWEB) March 08, 2014
Lipitor lawsuits (http://www.lipitorlawsuitcenter.com/) that claim the statin drug caused patients to develop new-onset Type 2 diabetes continue to mount in courts around the country, Bernstein Liebhard LLP reports. According to court documents, four women recently filed claims in U.S. District Court, Northern District of West Virginia, that claim an association exists between the use of Lipitor and diabetes. The complaints, which were filed between February 3 and February 14, 2014, allege that Pfizer, Inc. sold Lipitor despite knowing its use is related to the development of Type 2 diabetes. (Case Nos. 14-cv-9, 14-cv-14, 14-cv-18 and 14-cv-22)
“The claims put fourth in these Lipitor lawsuits are similar to the allegations contained in dozens of similar cases filed in courts around the country. They also echo what we have heard from individuals who have contacted our Firm with inquiries about Lipitor,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Lipitor lawsuit consultations to anyone who may have developed Type 2 diabetes due to the use of this statin medication.
Lipitor Diabetes Claims
Lipitor is a statin drug used since the mid-1990s to treat high cholesterol. In January 2012, a study published in JAMA: Internal Medicine reported that post-menopausal women who take statin drugs like Lipitor may be at an increased risk for developing diabetes.* Following the publication of that study, the U.S. Food & Drug Administration (FDA) ordered all statin manufacturers to add new warnings to the drugs’ labels regarding their potential effects on blood sugar levels.
Court documents indicate that more than 60 Lipitor lawsuits have been filed in a multidistrict litigation now underway in U.S. District Court, District South Carolina. However, according to the Order establishing the federal Lipitor litigation, at least 170 additional claims have been filed in other federal courts that could ultimately be transferred to the proceeding. Among other things, these lawsuits claim that Pfizer failed to provide adequate warnings regarding the link between Lipitor and diabetes. Plaintiffs further allege that warnings added to the product label following the FDA’s 2012 mandate remain inadequate. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)
Lipitor patients who developed Type 2 diabetes may be entitled to compensation for medical bills, lost wages, pain and suffering and more. To find out more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free legal review, please call 800-511-5092.
*archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January 2012
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com